1. (1) Informed consent for psychotropic medication, physical treatment, and release of information shall be limited to the current RMHI admission. If a patient is discharged and subsequently readmitted, informed consent as required by these rules must be obtained for any psychotropic medication, physical treatment, and/or release of information related to the new admission.

2. (2) A consent for psychotropic medication or physical treatment remains effective until:

   1. (a) The patient who has consented or the patient’s conservator who has the authority to give consent expressly revokes the consent in writing or orally, or
   2. (b) The patient who has consented continuously refuses, either orally or behaviorally, to take the psychotropic medication or physical treatment for a 72-hour period, thereby revoking the consent.

3. (3) A release of information remains effective until:

   1. (a) The date, event or condition of expiration specified on the release of information form occurs, or
   2. (b) The patient who has consented or the patient’s conservator who has the authority to give consent expressly revokes the release of information in writing or orally.
   3. (c) The release of information expires automatically one (1) year from the date of signature.
4. (4) If, after revoking a consent, the patient or conservator subsequently indicates a willingness to have the psychotropic medication administered, to accept the physical treatment, and/or to allow release of information, the psychotropic medication, physical treatment, and/or release of information shall be resumed only after the patient gives a voluntary, informed consent in writing in accordance with Rules 0940-01-02-.04 and 0940-01-02-.06. If the patient continues to refuse psychotropic medication, and the treatment team deems that the medication is PSYCHOTROPIC MEDICATIONS AT MENTAL HEALTH INSTITUTES essential to the patient’s recovery, a TRC may be pursued in accordance with Rule 0940-01- 02-.10.

5. (5) Revocation of informed consent shall be documented as follows:

   1. (a) If a patient or the patient’s conservator revokes a consent for psychotropic medication, the revocation shall be documented immediately in the patient’s medical record, and an order discontinuing the revoked psychotropic medication shall be written by a member of the RMHI Medical Staff. Refer to 0940-01-02-.07 related to the administration of emergency medications in the event of an emergency situation.
   2. (b) If a patient or the patient’s conservator revokes a consent for physical treatment, the revocation shall be documented immediately in the patient’s medical record, and an order discontinuing the revoked physical treatment shall be written by a member of the RMHI Medical Staff.
   3. (c) If a patient or the patient’s conservator revokes a release of information, the revocation shall be documented immediately on the Revocation of Authorization to Release Confidential Information Form and maintained in the patient’s medical record.
6. (6) A patient or the patient’s conservator may decide to partially revoke consent, retaining consent for part of the psychotropic medications, physical treatment, and/or release of information included on the consent. The written documentation of the partial revocation must clearly reflect which parts of the consent are revoked and which are retained.

Authority: T.C.A. §§ 33-1-302 through 33-1-305, 33-3-104, 33-6-107, and 33-6-1006. Administrative History: (For Administrative History prior to February, 1985 see page 1.001). New rule filed January 9, 1985; effective February 8, 1985. Amendments filed December 22, 2025; effective March 22, 2026.